Addiction & Substance Use

Here are highlights from this week in Psychiatric Times, including FDA approvals and conference coverage.

A professional's battle with alcoholism escalated from social drinking to daily dependence, impacting work and relationships until a pivotal moment led to seeking rehab and recovery.

What are some of the best medical interventions for alcohol use disorder?

Learn how clinicians can better recognize, diagnose, and support patients struggling with addiction through proactive screening and honest conversations.

How can a whole-patient approach improve treatment for alcohol use disorder (AUD)? Joseph Volpicelli, MD, PhD, shares expert insights on evidence-based strategies, patient collaboration, and the role of medications like naltrexone in long-term recovery.

Joseph Volpicelli MD, PhD, reflects on 40 years of advancements in addiction treatment, from overcoming stigma to integrating evidence-based therapies like naltrexone.

Chris Schenewerk, MD, shares how his battle with alcohol addiction transformed his understanding of addiction treatment.

How can personalized care, addressing comorbidities, and focusing on gradual improvement help increase treatment success for alcohol use disorder?

Understanding the complex relationship between substance use and mental health is critical to providing thorough and well-informed evaluations. Let's take a look at the relationship between cannabis and criminal responsibility.

How can psychiatric clinicians ensure their practices are accessible to patients with disabilities?

Stephanie Gorka, PhD, shared findings at the ACNP Annual Meeting on orexin receptor agonists addressing AUDs.

While complete abstinence is a good goal, what other clinically meaningful endpoints are there for patients with substance use disorders? Learn more in this ACNP 2024 Annual Meeting session!

Inhalant use disorder is a form of substance use disorder characterized by the intentional inhalation of volatile substances for their psychoactive effects.

As a treatment, low-dose lithium can act like a bridge between medications and integrative approaches, supporting well-being with reduced adverse effects.

Novel treatment for cocaine use disorder? Researchers performed a randomized, double-blind, placebo-controlled trial of lorcaserin.

This book seeks to reduce the stigma surrounding teen pregnancy.

Learn more about the latest viral substance abuse trend.

Enter your email to check out this complicated case!

In this CME article, learn how best to provide end-of-life care to patients with psychiatric disorders.

Assisted outpatient treatment is not intended to replace comprehensive, easy-to-access, voluntary treatment. Here's why we need it, according to one expert.

Learn more about the latest research related to 9/11 trauma and other psychiatric comorbidities.

When psychiatrists fully embrace psychopharmacological interventions as integral components of addiction treatment, patients can begin a journey toward sustainable recovery.

Tomorrow, August 31, is Overdose Awareness Day. What can you be doing to help prevent overdose deaths?

In this CME article, learn more about how to assess the impact of alcohol and cannabis use on anxiety treatment outcomes, recognizing potential adverse effects and interactions.

Cannabis use during adolescence can profoundly impact brain development.